Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Recursion Pharmaceuticals, Inc. (RXRX)

3.5200 +0.0200 (+0.57%)
At close: November 6 at 4:00:00 PM EST
3.5278 +0.0078 (+0.22%)
After hours: November 6 at 7:59:37 PM EST
Trade RXRX on Coinbase

News headlines

Updated 10m ago
Powered by Yahoo Scout

Recursion Pharmaceuticals reported Q3 2026 results alongside encouraging clinical data for REC-4881 and REC-1245. The company raised roughly $200 million, ended September with approximately $749 million in pro forma cash, and extended its projected cash runway into 2029. The central question is whether clinical progress and partnerships can offset continued losses and future dilution risk.

Mobilize your Website
View Site in Mobile | Classic
Share by: